How Long Does It Take Semaglutide to Work After Injection?

Last reviewed: June 10, 2026

Last updated: June 10, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that works by slowing stomach emptying and activating brain centers that control hunger. Many patients report noticing appetite suppression within the first week of injections, though the full metabolic benefits develop over several weeks. This timeline matters because it shapes your experience and helps you stay committed to your treatment plan.

Semaglutide Injection Timeline: First Week Expectations

During your first injection, semaglutide begins binding to GLP-1 receptors in your digestive tract and brain almost immediately. However, most patients don't consciously feel significant appetite changes in the first 24–48 hours because the initial dose is low (typically 0.25 mg). Some people notice mild nausea, fatigue, or subtle decreases in food cravings by day 3–5, while others experience no noticeable shift until week 2.

The PlexusDx Precision Peptide Genetic Test reports on variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

When Does Meaningful Weight Loss Start on Semaglutide?

Clinical trials show that measurable weight reduction typically appears after 2–4 weeks of consistent semaglutide use, coinciding with dose escalation schedules. During week 1, your body adjusts to the medication; by weeks 2–3, reduced calorie intake from decreased appetite begins to shift the scale downward. Most patients see 2–5 pounds of weight loss in the first month, with faster results if combined with structured eating patterns and movement.

The GLP-1 mechanism doesn't create sudden dramatic drops—instead, it reduces the drive to overeat, making a 500–1000 calorie daily deficit feel effortless rather than restrictive. By week 4–6, as your dose increases toward therapeutic levels (0.5–1.0 mg), fat loss accelerates and becomes more noticeable in how clothes fit and energy levels improve. Sustained weight loss of 1–2 pounds per week is realistic after the first month on an appropriate dose.

Dose Escalation Schedule and Its Effect on Results Timeline

PlexusDx Compounded Semaglutide Injections follow a standard four-week titration: 0.25 mg week 1, 0.5 mg week 2, 0.75 mg week 3, and 1.0 mg week 4. Each dose increase amplifies the appetite-suppressing effect, meaning your body experiences progressively stronger signals to eat less. The cumulative effect means that by week 4, you're receiving 3–4 times the appetite reduction of your first injection, which explains why most patients see accelerating results between weeks 2 and 6.

Your dose may need to go up. Your price won't—PlexusDx charges a flat monthly rate regardless of whether you're at 0.25 mg or 2.4 mg, removing financial barriers to reaching your optimal therapeutic level. This approach ensures you receive the dose your body needs without worrying about escalating costs as your treatment advances.

Factors That Influence How Fast Semaglutide Works

Your starting weight, metabolism, insulin sensitivity, and dietary habits all shape how quickly semaglutide produces visible results. People with higher baseline body weight and metabolic resistance often need 6–8 weeks to see clear progress, while those with better metabolic health may notice changes within 2–3 weeks. Consistency matters enormously—missing doses or irregular injection timing can delay the onset of steady results by weeks.

The PlexusDx Precision Peptide Genetic Test ($298) analyzes GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Why don't I feel semaglutide working after my first injection?

The starting dose (0.25 mg) is intentionally low to minimize side effects and let your body adjust. Meaningful appetite suppression typically emerges by days 3–7 and becomes pronounced after your second or third injection when the dose increases. If you feel nothing after week 2, discuss your experience with your PlexusDx provider, as individual response times vary and genetic factors may influence your timeline.

How much weight can I expect to lose in the first month of semaglutide injections?

Clinical data shows average weight loss of 2–5 pounds in month one, with variation based on starting weight, adherence, and metabolic rate. Heavier individuals and those with insulin resistance sometimes lose more, while slower metabolizers may see 1–2 pounds initially. By month 2–3, once you're at a therapeutic dose, monthly losses of 4–8 pounds become more typical.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Is nausea during the first week normal, and will semaglutide still work if I feel sick?

Mild nausea in days 1–7 is common and typically subsides within 5–7 days as your body adapts. Nausea does not mean semaglutide isn't working—in fact, it often signals that the medication is engaging your GLP-1 receptors. Stay hydrated, eat light meals, and avoid fatty or spicy foods; if nausea persists beyond day 10, contact your PlexusDx provider about dose timing or complementary strategies.

What if I'm a slow responder to semaglutide—will I ever see results?

Yes, but your timeline may extend to 8–12 weeks for visible progress. Genetic variants in your FTO pathways influence response speed; the Precision Peptide Genetic Test identifies slow-responder profiles so your provider can adjust strategy early. Even slow responders eventually achieve results—the difference is weeks, not whether results occur.

Related Reading

• Injection Semaglutide
• Semaglutide Providers That Take Fsa Plexusdx
• Semaglutide Injection
• How Long Does Mthfr Test Take

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.